Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse. - Wikidata - awgldk - TriplyDB

Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

http://www.wikidata.org/entity/Q34764685

about

Effects of epithelial to mesenchymal transition on T cell targeting of melanoma cells The profile of tumor antigens which can be targeted by immunotherapy depends upon the tumor's anatomical site.Mutated BRAF Emerges as a Major Effector of Recurrence in a Murine Melanoma Model After Treatment With Immunomodulatory Agents Cytokine conditioning enhances systemic delivery and therapy of an oncolytic virus.Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling.Entropic analysis reveals a connection between the recurrence of cancer and chemotherapy.Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy Immunotherapy exposes cancer stem cell resistance and a new synthetic lethality Detecting and targeting tumor relapse by its resistance to innate effectors at early recurrence.Immunogenicity of self tumor associated proteins is enhanced through protein truncation.Glioma virus therapies between bench and bedside.Oncolytic vaccines.Topoisomerase 2 Alpha Cooperates with Androgen Receptor to Contribute to Prostate Cancer Progression EMT, CSCs, and drug resistance: the mechanistic link and clinical implications.Trick and treat: Ambushing recurrent tumors before they get out of the door.Promising immunotherapy for prostate cancer.Subversion of NK-cell and TNFα Immune Surveillance Drives Tumor Recurrence.Polymer-Based Nanocarriers for Co-Delivery and Combination of Diverse Therapies against Cancers.

P2860

Q34722210-9F3A1AEB-8DC3-44A1-991A-E52C92828F7A Q35212733-14B8ADD8-E5EB-4591-8A77-C3ADAAF7AFDB Q35534823-287CBDDF-8F33-4CFD-98C1-55DBF217B888 Q35596563-AABFB0DE-B0C6-4054-893D-1EA968CDBBF3 Q35789319-309C8F89-410C-4BAB-B26A-18FC70BB32F8 Q36221559-A81535C1-1850-4889-8BA8-75983655F0D8 Q36928875-2108BAF0-DFDA-4C3F-9213-A8F6E48E2282 Q37086890-346B7F1B-94FB-4E51-A449-EF64C88C4E67 Q37477557-5FB22EE0-8AD8-444A-BD4E-A27C8638BEA1 Q37481401-E11B86DA-CE5C-458D-B276-BD0789045C77 Q37580510-62536164-980B-41FC-BD56-475827E99E2F Q38152474-8A96F75A-8BD6-43DF-ACC3-D9C8569A7EE1 Q38820055-33D0A276-31BF-4393-B320-10DDC54A246E Q39233875-4ABB9965-2049-466F-B0E8-7D4B2305992F Q42180796-4EB54429-B198-4CAD-8376-5735689EA930 Q47566793-088AA0A7-9A8A-4D4E-9744-79FC24F7A30A Q47781149-8796EB67-F92E-49E0-9B7F-F91B3D789807 Q52699514-09EE634E-5CF6-4E88-AFB2-F8998588CD60

P2860

Functional cloning of recurrence-specific antigens identifies molecular targets to treat tumor relapse.

http://www.wikidata.org/entity/Q34764685

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Functional cloning of recurren ...... argets to treat tumor relapse.

@ast

Functional cloning of recurren ...... argets to treat tumor relapse.

@en

Functional cloning of recurren ...... argets to treat tumor relapse.

@en-gb

Functional cloning of recurren ...... argets to treat tumor relapse.

@nl

type

label

Functional cloning of recurren ...... argets to treat tumor relapse.

@ast

Functional cloning of recurren ...... argets to treat tumor relapse.

@en

Functional cloning of recurren ...... argets to treat tumor relapse.

@en-gb

Functional cloning of recurren ...... argets to treat tumor relapse.

@nl

prefLabel

Functional cloning of recurren ...... argets to treat tumor relapse.

@ast

Functional cloning of recurren ...... argets to treat tumor relapse.

@en

Functional cloning of recurren ...... argets to treat tumor relapse.

@en-gb

Functional cloning of recurren ...... argets to treat tumor relapse.

@nl

P1433

Q34764685-8DC0E22A-2A54-4B38-987D-79E74E015445

P1476

Q34764685-A5F416AD-D6D4-4A5A-B9B3-0D964CB4FB6D

P2093

Q34764685-2FDCB652-6EA9-4939-A80C-CB941BF19C33

Q34764685-35471276-0EE7-4CB0-9BDA-55E8EEA5427F

Q34764685-3D354F4A-1C49-4A7D-A677-18C4C3D1DE60

Q34764685-3FF3FF6A-3E97-4F7A-8DD0-70C0626AACEE

Q34764685-65CC7A33-4129-4B78-8D23-2427B9559C1C

Q34764685-6AD49D28-55C0-4A59-B4C7-6F514DDA159D

Q34764685-8BDC60FD-1D19-4C25-932C-900FBE201FCF

Q34764685-97908397-7C81-4639-8408-64403F2E7277

Q34764685-BBB414D0-D145-4B61-B3EE-7C86EBB66F69

Q34764685-E517E20B-EFAC-4DB1-9ED4-DBC12353A715

P2860

Q34764685-0155B37D-7CD3-4B67-B8CC-11B7AEEFAB13

Q34764685-038548F9-06E2-452F-A23C-4CF020623B15

Q34764685-04D37644-56A6-4187-8310-9FEBCC611847

Q34764685-04EB87F5-0510-439D-8F40-EA0E7AC8EB9B

Q34764685-0534ADC5-63E0-421A-A14C-DA8939C23077

Q34764685-073D4F3A-DB65-404D-80EE-9DFA45B086A2

Q34764685-10CF2127-4A5A-4FDB-B132-7008D51E832F

Q34764685-12530857-4BAE-4736-AFDD-E39024BF0B59

Q34764685-27266208-1FB2-43F9-BDB6-70ABC196C251

Q34764685-27626837-0DCA-4F56-806A-3C9988B2DE00

P304

Q34764685-2E9ACAEE-46C4-458B-A317-51F67432001E

P31

Q34764685-0A1D2E54-2882-456F-963D-3AB840053167

P356

Q34764685-A90325FF-F54F-49C9-9E80-61874764DB58

P433

Q34764685-0A1BA83D-584B-43B5-B25F-9849BEEA31AB

P478

Q34764685-9149F4C3-B854-4BDC-8912-DE92B5BCFBCA

P50

Q34764685-57FA7EEE-ED18-4033-B3BB-AE73A075B4AE

Q34764685-A5DFA057-F7F7-4D20-8FA3-5AD612CE065C

Q34764685-CD669A0E-CA9E-498C-AA16-77F3D596AE2C

P5530

Q34764685-58D1DC51-79D6-4232-AF1D-56D0059D72E2

P577

Q34764685-3A9D09DC-C68C-46F4-AC84-AAAB602D6648

P5875

Q34764685-723DA686-03CC-4425-8ABB-0574BD0F855F

P6179

Q34764685-CB5BF6EB-30D6-4B39-99A1-B3B749351AFA

P698

Q34764685-47987936-C5BD-4D60-A0E1-D206A4298902

P932

Q34764685-2E754AF6-7F0E-490F-BA66-043708C31542

P356

P1433

Molecular Therapy

P1476

Functional cloning of recurren ...... argets to treat tumor relapse.

@en

P2093

Addie Embry

http://www.w3.org/2001/XMLSchema#string

Diana Rommelfanger-Konkol

http://www.w3.org/2001/XMLSchema#string

Dyana Saenz

http://www.w3.org/2001/XMLSchema#string

Eric Poeschla

http://www.w3.org/2001/XMLSchema#string

Hardev Pandha

http://www.w3.org/2001/XMLSchema#string

Jill Thompson

http://www.w3.org/2001/XMLSchema#string

Jose Pulido

http://www.w3.org/2001/XMLSchema#string

Kevin Harrington

http://www.w3.org/2001/XMLSchema#string

Richard Vile

http://www.w3.org/2001/XMLSchema#string

Rosa Maria Diaz

http://www.w3.org/2001/XMLSchema#string

P2860

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

Targeting DNA topoisomerase II in cancer chemotherapy

The basics of epithelial-mesenchymal transition

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits

Intra-tumour heterogeneity: a looking glass for cancer?

Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?

Broad antigenic coverage induced by vaccination with virus-based cDNA libraries cures established tumors

Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma.

Immunity to cancer through immune recognition of altered self: studies with melanoma.

P304

1507-1516

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/MT.2013.116

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Nicolas Boisgerault

P5530

6055185

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237096853

http://www.w3.org/2001/XMLSchema#string

P6179

1004756174

http://www.w3.org/2001/XMLSchema#string

P698

23752316

http://www.w3.org/2001/XMLSchema#string

P932

3734666

http://www.w3.org/2001/XMLSchema#string